Targeted Left Ventricular Lead Implantation Strategy for Non-Left Bundle Branch Block Patients: The ENHANCE CRT Study

Area of Science:

• Cardiology
• Medical Devices
• Clinical Trials

Background:

• Limited data exist on cardiac resynchronization therapy (CRT) effectiveness in non-left bundle branch block (NLBBB) patients.
• Conventional CRT implantation relies on an anatomical approach.
• Targeting the latest activated region (QLV) may offer an individualized strategy for NLBBB patients.

Purpose of the Study:

• To compare clinical outcomes between a QLV-based LV lead implantation approach and a conventional anatomical implantation approach in NLBBB patients.
• To evaluate the effectiveness of CRT in NLBBB patients using a novel lead placement strategy.

Main Methods:

• A randomized controlled trial involving 248 subjects with NLBBB at 29 U.S. centers.
• Subjects were randomized 2:1 to either QLV-based or anatomical LV lead implantation using a St. Jude Medical quadripolar CRT-D system.
• The primary endpoint was the clinical composite score at 12 months post-implantation.

Main Results:

• 191 subjects (128 QLV arm, 63 control arm) were analyzed at 12 months.
• The responder rate at 12 months was 67.2% in the QLV arm and 73.0% in the control arm (p=0.506).
• No significant differences in baseline characteristics or heart failure events were observed between the groups.

Conclusions:

• Patient-tailored LV lead placement guided by QLV did not demonstrate improved outcomes compared to the conventional anatomical approach in NLBBB patients.
• The study observed no significant difference in clinical outcomes between the two implantation strategies.
• Further research may be needed to explore the potential benefits of QLV-guided implantation in specific patient subgroups.